News

(Bloomberg) -- Emergent BioSolutions Inc. led an advance in the stocks of companies working on vaccines and antiviral products this week as investors await word from US regulators on if its smallpox vaccine can also be used for the fast-spreading mpox virus. Most Read from BloombergManchester Is Giving London a Run for Its MoneyBoston’s Broke and Broken Transit System Hurts Downtown RecoveryA Floating Island in Baltimore Raises Hope for a Waterfront RevivalA Warehouse Store Promises Housing for

(Bloomberg) -- It looked like a reckoning was arriving on August 5, when the Nasdaq 100 tumbled over 5% in the seconds after the opening bell, validating fears that a tech bubble was about to burst. Most Read from BloombergManchester Is Giving London a Run for Its MoneyBoston’s Broke and Broken Transit System Hurts Downtown RecoveryA Floating Island in Baltimore Raises Hope for a Waterfront RevivalA Warehouse Store Promises Housing for South LA, in BulkThe Cross-Continental Race Using Only Publi

The workflow software platform keeps putting up impressive growth figures.

These three top cryptocurrencies are seeing selling pressure build today.

Rivian announced a temporary suspension in production of its Amazon delivery vans.

The AI trade is back on.

The company's earnings pleased investors.

Here are the stocks making the biggest market moves today.

"You don't want to tighten any longer than you have to," Goolsbee told National Public Radio in an interview. Goolsbee declined to say whether he would press for an interest rate cut at the Fed's coming meeting on Sept. 17-18. The Fed has held its policy rate in the current range of 5.25% to 5.50% since July 2023 after raising to that level at a breakneck pace over the prior 16 months to combat the worst outbreak of inflation since the 1980s.